Deputy Head of Clinical Investigations

Job summary

We are seeking aproactive, confidentand enthusiasticDeputy Head of Clinical Investigationsto join ourInnovation AcceleratorfunctioninScientific Research & Innovationgroup. This is afull-timeopportunityon afixed-term/loan/secondment basis until 31stMarch 2025.

The role will be based in 10 South Colonnade, Canary Wharf London, E14 4PU and/or our South Mimms, Hertfordshire site. Please be aware that this role can only be worked in the UK and not overseas. We are currently implementing a flexible, hybrid way of working, with a minimum of 4 days per month working on site to enable the collaboration and contact with partners and stakeholders needed to deliver MHRA business. Attendance on site is driven by business needs so depending on the nature of the role, this can flex up to 8 days a month, with the remainder of time worked either remotely or in the office. Some roles will need to be on site more regularly. Remote working is potentially available for some specific roles. Please discuss this with the recruiting manager before accepting an appointment.

TO BE CONSIDERED FOR THIS ROLE, PLEASE APPLY ON MHRA WEBSITE (http://lhrc1a.rfer.us/MHRAh.l1Fm). ONLY APPLICATIONS RECEIVED ON MHRA WEBSITE WILL BE CONSIDERED

Main duties of the job

The key purpose of this role is to work in collaboration with the Head of the Integrated Devices Access Pathway and Head of Clinical Investigations to ensure the efficient, pragmatic, proportionate and patient-centred performance of the clinical and non-clinical assessment of clinical investigations into the performance and safety of medical devices and diagnostics.

The role offers an exciting opportunity to be at the forefront of medical device innovation to address unmet patient needs.The post holder will also participate in the deployment of the Innovative Devices Access Pathway (IDAP). The aim of the pathway is to improve patient access to innovative technologies by providing developers with joined up support and advice from across the UK.

About us

The Medicines and Healthcare products Regulatory Agency enhance and improve the health of millions of people every day through the effective regulation of medicines and medical devices, underpinned by science and research.

The Science, Research, and Innovation Group delivers public health impact, world-leading research innovation, and a unique proposition via an ambitious Science Strategy which will balance innovation against sustainability and affordability. It is divided into 6 sub-Groups, Innovation Accelerator, Clinical Investigations and Trials, Research and Development, Standards Lifecycle, Control Testing and Quality Assurance and Health & Safety.

The Innovation Accelerator (IA) provides innovators access to the Agencys scientific expertise and regulatory guidance, helping developers of innovative products (medicines, medical devices (including software) and blood components for transfusion) connect more dynamically with an enhanced advice and signposting service.